178 related articles for article (PubMed ID: 12126937)
41. Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres.
Iannone MA; Consler TG; Pearce KH; Stimmel JB; Parks DJ; Gray JG
Cytometry; 2001 Aug; 44(4):326-37. PubMed ID: 11500849
[TBL] [Abstract][Full Text] [Related]
42. Selective estrogen receptor modulators suppress mesangial cell collagen synthesis.
Neugarten J; Acharya A; Lei J; Silbiger S
Am J Physiol Renal Physiol; 2000 Aug; 279(2):F309-18. PubMed ID: 10919851
[TBL] [Abstract][Full Text] [Related]
43. Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains.
Métivier R; Penot G; Flouriot G; Pakdel F
Mol Endocrinol; 2001 Nov; 15(11):1953-70. PubMed ID: 11682626
[TBL] [Abstract][Full Text] [Related]
44. Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland.
Crabtree JS; Peano BJ; Zhang X; Komm BS; Winneker RC; Harris HA
Mol Cell Endocrinol; 2008 Jun; 287(1-2):40-6. PubMed ID: 18367319
[TBL] [Abstract][Full Text] [Related]
45. Identification of coregulators influenced by estrogen receptor subtype specific binding of the ER antagonists 4-hydroxytamoxifen and fulvestrant.
Evers NM; Wang S; van den Berg JH; Houtman R; Melchers D; de Haan LH; Ederveen AG; Groten JP; Rietjens IM
Chem Biol Interact; 2014 Sep; 220():222-30. PubMed ID: 25014417
[TBL] [Abstract][Full Text] [Related]
46. AIB1 gene amplification and the instability of polyQ encoding sequence in breast cancer cell lines.
Wong LJ; Dai P; Lu JF; Lou MA; Clarke R; Nazarov V
BMC Cancer; 2006 May; 6():111. PubMed ID: 16670003
[TBL] [Abstract][Full Text] [Related]
47. Ligand-selective interactions of ER detected in living cells by fluorescence resonance energy transfer.
Weatherman RV; Chang CY; Clegg NJ; Carroll DC; Day RN; Baxter JD; McDonnell DP; Scanlan TS; Schaufele F
Mol Endocrinol; 2002 Mar; 16(3):487-96. PubMed ID: 11875107
[TBL] [Abstract][Full Text] [Related]
48. Interaction of transcriptional intermediary factor 2 nuclear receptor box peptides with the coactivator binding site of estrogen receptor alpha.
Wärnmark A; Treuter E; Gustafsson JA; Hubbard RE; Brzozowski AM; Pike AC
J Biol Chem; 2002 Jun; 277(24):21862-8. PubMed ID: 11937504
[TBL] [Abstract][Full Text] [Related]
49. Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1.
Dahm AE; Iversen N; Birkenes B; Ree AH; Sandset PM
BMC Cardiovasc Disord; 2006 Oct; 6():40. PubMed ID: 17029634
[TBL] [Abstract][Full Text] [Related]
50. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
Kallio A; Guo T; Lamminen E; Seppänen J; Kangas L; Väänänen HK; Härkönen P
Mol Cell Endocrinol; 2008 Jul; 289(1-2):38-48. PubMed ID: 18455292
[TBL] [Abstract][Full Text] [Related]
51. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways.
Voegel JJ; Heine MJ; Tini M; Vivat V; Chambon P; Gronemeyer H
EMBO J; 1998 Jan; 17(2):507-19. PubMed ID: 9430642
[TBL] [Abstract][Full Text] [Related]
52. Development of peptide antagonists that target estrogen receptor beta-coactivator interactions.
Hall JM; Chang CY; McDonnell DP
Mol Endocrinol; 2000 Dec; 14(12):2010-23. PubMed ID: 11117531
[TBL] [Abstract][Full Text] [Related]
53. Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands.
Hershberger PA; Vasquez AC; Kanterewicz B; Land S; Siegfried JM; Nichols M
Cancer Res; 2005 Feb; 65(4):1598-605. PubMed ID: 15735050
[TBL] [Abstract][Full Text] [Related]
54. Molecular determinants for the tissue specificity of SERMs.
Shang Y; Brown M
Science; 2002 Mar; 295(5564):2465-8. PubMed ID: 11923541
[TBL] [Abstract][Full Text] [Related]
55. Myometrial effects of selective estrogen receptor modulators on estradiol-responsive gene expression are gene and cell-specific.
Farnell YZ; Ing NH
J Steroid Biochem Mol Biol; 2003 Apr; 84(5):527-36. PubMed ID: 12767277
[TBL] [Abstract][Full Text] [Related]
56. Competition between thyroid hormone receptor-associated protein (TRAP) 220 and transcriptional intermediary factor (TIF) 2 for binding to nuclear receptors. Implications for the recruitment of TRAP and p160 coactivator complexes.
Treuter E; Johansson L; Thomsen JS; Wärnmark A; Leers J; Pelto-Huikko M; Sjöberg M; Wright AP; Spyrou G; Gustafsson JA
J Biol Chem; 1999 Mar; 274(10):6667-77. PubMed ID: 10037764
[TBL] [Abstract][Full Text] [Related]
57. Steroid receptor coactivator-2 expression in brain and physical associations with steroid receptors.
Yore MA; Im D; Webb LK; Zhao Y; Chadwick JG; Molenda-Figueira HA; Haidacher SJ; Denner L; Tetel MJ
Neuroscience; 2010 Sep; 169(3):1017-28. PubMed ID: 20678994
[TBL] [Abstract][Full Text] [Related]
58. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
[TBL] [Abstract][Full Text] [Related]
59. Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer.
Zhou G; Cummings R; Li Y; Mitra S; Wilkinson HA; Elbrecht A; Hermes JD; Schaeffer JM; Smith RG; Moller DE
Mol Endocrinol; 1998 Oct; 12(10):1594-604. PubMed ID: 9773982
[TBL] [Abstract][Full Text] [Related]
60. Differential actions of estrogen and SERMs in regulation of the actin cytoskeleton of endometrial cells.
Flamini MI; Sanchez AM; Goglia L; Tosi V; Genazzani AR; Simoncini T
Mol Hum Reprod; 2009 Oct; 15(10):675-85. PubMed ID: 19541800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
